Form 4: Beneficient Executive Jeff Welday Sells Shares to Cover Tax Obligations
SEC Form 4
Beneficient's Global Head of Organizations and Distribution, Jeff Welday, sold a total of 3,623 shares of Class A Common Stock to cover tax obligations related to vesting of restricted stock units.
Summary
- Jeff Welday, Global Head of Organizations and Distribution at Beneficient, sold 3,623 shares of Class A Common Stock between December 5th and December 9th, 2024.
- The sales were executed at prices of $0.81 and $0.82 per share.
- These transactions were made to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- Following these transactions, Welday still beneficially owns 100,367 shares of Class A Common Stock.
- The shares are related to multiple RSU grants from 2018, 2020, 2022, 2023 and 2024 under the company's equity incentive plans.
Sentiment
Score: 6
Explanation: The document is neutral, detailing routine stock sales for tax purposes. It doesn't indicate any positive or negative sentiment about the company's performance or future prospects.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, although these sales were explicitly for tax obligations.
- The stock price could be sensitive to further sales by insiders.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the standard practice of executives selling shares to cover tax obligations upon vesting of equity awards.
Comparison to Industry Standards
- Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
- The vesting schedules and equity incentive plans described are typical for companies using equity as part of their compensation packages.
- The sale prices are reflective of the current market price of the stock at the time of the transactions.
Stakeholder Impact
- The stock sales may have a minor impact on the stock price, but are not expected to significantly affect shareholders.
- The transactions are part of the executive compensation structure and do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2020-01-01 | Grant date of 140,490 REUs under the 2018 Equity Incentive Plan, vesting 20% on grant date and the remaining 80% in four equal annual installments on June 3rd of each subsequent calendar year. |
| 2022-04-01 | Grant date of 7,200 REUs under the 2018 Equity Incentive Plan, vesting 40% on June 8, 2023, and the remaining 60% in three equal annual installments on April 1st of each subsequent calendar year. |
| 2023-07-15 | Grant date of 28,320 RSUs under the 2023 Equity Incentive Plan, vesting 20% on September 1, 2023, and the remaining 80% in four equal annual installments on September 1st of each subsequent calendar year. |
| 2023-07-15 | Grant date of 20,560 RSUs under the 2023 Equity Incentive Plan, fully vested on September 1, 2023. |
| 2023-09-01 | Vesting date for 20% of 28,320 RSUs granted on July 15, 2023, and full vesting date for 20,560 RSUs granted on July 15, 2023. |
| 2024-08-22 | Grant date of 98,919 RSUs and 998 RSUs under the 2023 Equity Incentive Plan, both fully vested on the date of grant. |
| 2024-10-17 | Grant date of 58,249 RSUs under the 2023 Equity Incentive Plan, fully vested on the date of grant. |
| 2024-12-05 | First sale of 1,091 shares at $0.81 per share. |
| 2024-12-06 | Second sale of 1,823 shares at $0.81 per share. |
| 2024-12-09 | Third sale of 709 shares at $0.82 per share. |
Keywords
Beneficient, Jeff Welday, stock sale, insider trading, Form 4, RSU, restricted stock units, equity incentive plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.